Lipocalin-2 Is an Inflammatory Marker Closely Associated with Obesity, Insulin Resistance, and Hyperglycemia in Humans | Zendy

Yu Wang | Zendy; Karen S.L. Lam | Zendy; Edward W. Kraegen | Zendy; Gary Sweeney | Zendy; Jialiang Zhang | Zendy; Annette Wk Tso | Zendy; Wing-Sun Chow | Zendy; Nelson M.S. Wat | Zendy; Jian Xu | Zendy; Ruby LC Hoo | Zendy; Aimin Xu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lipocalin-2 Is an Inflammatory Marker Closely Associated with Obesity, Insulin Resistance, and Hyperglycemia in Humans

Author(s) -

Yu Wang,

Karen S.L. Lam,

Edward W. Kraegen,

Gary Sweeney,

Jialiang Zhang,

Annette Wk Tso,

Wing-Sun Chow,

Nelson M.S. Wat,

Jian Xu,

Ruby LC Hoo,

Aimin Xu

Publication year - 2006

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2006.075614

Subject(s) - lipocalin , medicine , insulin resistance , endocrinology , rosiglitazone , adipose tissue , insulin , diabetes mellitus , obesity , biomarker , biology , biochemistry

Lipocalin-2, a 25-kDa secreted glycoprotein, is a useful biomarker for early detection of various renal injuries. Because lipocalin-2 is abundantly expressed in adipose tissue and liver, we investigated its relevance to obesity-related pathologies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research